Manipal Health Enterprises IPO Sees 45% Subscription by Day 2, GMP Remains Muted
Key Takeaways
- •Manipal Health Enterprises' IPO, valued at approximately ₹9,275 crore, achieved a 45% overall subscription rate as of 5:00 p.m. on July 30, indicating bids covered less than half of the shares on offer.
- •The public offering is structured as a pure Offer for Sale by existing shareholders, with proceeds going to selling stakeholders rather than fresh capital deployment by the company.
- •The grey market premium for the IPO has remained muted, reflecting limited investor enthusiasm in the unofficial secondary market ahead of listing.
- •Manipal Health Enterprises operates a network of multi-specialty hospitals across multiple Indian cities and is among the country's prominent healthcare service providers.
- •Indian IPOs frequently experience a surge in bidding on the final day, particularly from institutional investors, making early subscription figures an incomplete indicator of final demand.
The initial public offering (IPO) of Manipal Health Enterprises, valued at approximately ₹9,275 crore, has encountered a subdued response from investors during its initial bidding period. The issue opened for subscription on July 29 and, as of 5:00 p.m. on July 30, had achieved an overall subscription rate of 45%. The offering is a pure Offer for Sale (OFS) by existing shareholders, meaning proceeds will go to selling stakeholders rather than fresh capital deployment by the company.
The grey market premium (GMP) for the IPO has remained muted, reflecting limited enthusiasm in the unofficial secondary market ahead of the listing. The GMP is an indicator that traders in the unofficial grey market use to estimate the potential listing price of an IPO, though it carries no official standing and can fluctuate significantly.
Manipal Health Enterprises is one of India's prominent healthcare service providers, operating a network of multi-specialty hospitals across multiple cities. The company's public offering represents one of the significant IPOs in the Indian healthcare sector in recent times, coming amid sustained investor interest in hospital chains driven by rising healthcare demand, expanding insurance penetration, and growth in medical tourism. The sector has seen several notable listings in recent years, including those of Narayana Health and Rainbow Children's Medicare, as private hospital operators tap public markets to fuel expansion.
In the Indian IPO subscription framework, overall subscription is tracked across categories, including Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs). A 45% overall subscription at this stage indicates that total bids received covered less than half of the shares on offer. However, Indian IPOs frequently see a surge in bidding on the final day, particularly from institutional investors, making early subscription figures an incomplete indicator of final demand.
The subscription window, pricing details, and allotment and listing dates are part of the IPO schedule published in the company's red herring prospectus. Investors can check allotment status through the registrar's website once the basis of allotment is finalized.